183 related articles for article (PubMed ID: 31669777)
1. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
Deng L; Liu H; Ma Y; Miao Y; Fu X; Deng Q
Toxicol Appl Pharmacol; 2019 Dec; 384():114765. PubMed ID: 31669777
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice.
Lin Z; Monteiro-Riviere NA; Riviere JE
Nanotoxicology; 2016; 10(2):162-72. PubMed ID: 25961857
[TBL] [Abstract][Full Text] [Related]
3. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats.
Chou WC; Cheng YH; Riviere JE; Monteiro-Riviere NA; Kreyling WG; Lin Z
Part Fibre Toxicol; 2022 Jul; 19(1):47. PubMed ID: 35804418
[TBL] [Abstract][Full Text] [Related]
4. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution.
Sun YN; Wang CD; Zhang XM; Ren L; Tian XH
J Nanosci Nanotechnol; 2011 Feb; 11(2):1210-6. PubMed ID: 21456161
[TBL] [Abstract][Full Text] [Related]
5. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.
Carlander U; Li D; Jolliet O; Emond C; Johanson G
Int J Nanomedicine; 2016; 11():625-40. PubMed ID: 26929620
[TBL] [Abstract][Full Text] [Related]
6. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice.
Yang L; Kuang H; Zhang W; Aguilar ZP; Wei H; Xu H
Sci Rep; 2017 Jun; 7(1):3303. PubMed ID: 28607366
[TBL] [Abstract][Full Text] [Related]
8. Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration.
Wang J; Bai R; Yang R; Liu J; Tang J; Liu Y; Li J; Chai Z; Chen C
Metallomics; 2015 Mar; 7(3):516-24. PubMed ID: 25671498
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of single and aggregated gold nanoparticles exposed to the human lung epithelial tissue barrier at the air-liquid interface.
Durantie E; Vanhecke D; Rodriguez-Lorenzo L; Delhaes F; Balog S; Septiadi D; Bourquin J; Petri-Fink A; Rothen-Rutishauser B
Part Fibre Toxicol; 2017 Nov; 14(1):49. PubMed ID: 29187209
[TBL] [Abstract][Full Text] [Related]
10. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.
Liu X; Li H; Chen Y; Jin Q; Ren K; Ji J
Adv Healthc Mater; 2014 Sep; 3(9):1439-47. PubMed ID: 24550205
[TBL] [Abstract][Full Text] [Related]
11. Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.
Cheng YH; Riviere JE; Monteiro-Riviere NA; Lin Z
Nanotoxicology; 2018 Jun; 12(5):453-469. PubMed ID: 29658401
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.
Aborig M; Malik PRV; Nambiar S; Chelle P; Darko J; Mutsaers A; Edginton AN; Fleck A; Osei E; Wettig S
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31013763
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model.
Glazer ES; Zhu C; Hamir AN; Borne A; Thompson CS; Curley SA
Nanotoxicology; 2011 Dec; 5(4):459-68. PubMed ID: 20854190
[TBL] [Abstract][Full Text] [Related]
14. Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells.
Liu X; Huang N; Li H; Jin Q; Ji J
Langmuir; 2013 Jul; 29(29):9138-48. PubMed ID: 23815604
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys.
Jakic K; Selc M; Razga F; Nemethova V; Mazancova P; Havel F; Sramek M; Zarska M; Proska J; Masanova V; Uhnakova I; Makovicky P; Novotova M; Vykoukal V; Babelova A
Int J Nanomedicine; 2024; 19():4103-4120. PubMed ID: 38736658
[TBL] [Abstract][Full Text] [Related]
16. Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study.
Naz F; Koul V; Srivastava A; Gupta YK; Dinda AK
J Drug Target; 2016 Sep; 24(8):720-9. PubMed ID: 26837799
[TBL] [Abstract][Full Text] [Related]
17. In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats.
Li D; Morishita M; Wagner JG; Fatouraie M; Wooldridge M; Eagle WE; Barres J; Carlander U; Emond C; Jolliet O
Part Fibre Toxicol; 2016 Aug; 13(1):45. PubMed ID: 27542346
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in mice.
Chen WY; Cheng YH; Hsieh NH; Wu BC; Chou WC; Ho CC; Chen JK; Liao CM; Lin P
Int J Nanomedicine; 2015; 10():6277-92. PubMed ID: 26491297
[TBL] [Abstract][Full Text] [Related]
19. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
Morais T; Soares ME; Duarte JA; Soares L; Maia S; Gomes P; Pereira E; Fraga S; Carmo H; Bastos Mde L
Eur J Pharm Biopharm; 2012 Jan; 80(1):185-93. PubMed ID: 21946301
[TBL] [Abstract][Full Text] [Related]
20. A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an
Enea M; Peixoto de Almeida M; Eaton P; Dias da Silva D; Pereira E; Soares ME; Bastos ML; Carmo H
Nanotoxicology; 2019 Sep; 13(7):990-1004. PubMed ID: 31106633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
